Adeptus Biotechnologies Corp. (ADPT) PT Lowered to $13 at BTIG
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $26.71 +3.53%
Rating Summary:
13 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Rating Summary:
13 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Join SI Premium – FREE
BTIG analyst Mark Massaro lowered the price target on Adeptus Biotechnologies Corp. (NASDAQ: ADPT) to $13.00 (from $14.00) while maintaining a Buy rating.
You May Also Be Interested In
- Adaptive Biotechnologies Reports Third Quarter 2026 Financial Results
- Nomad Foods Ltd (NOMD) PT Raised to $15 at Jefferies
- GlobalFoundries Inc. (GFS) PT Lowered to $50 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
